IRulya Therapeutics (IRLA) Cash & Equivalents (2018 - 2026)
IRulya Therapeutics' Cash & Equivalents came in at $115.98 million for Q2 2026, up 589.3% from $16.83 million a year earlier and up 538.6% from the prior quarter.
Powered by 
Analysis
IRulya Therapeutics (IRLA) Cash & Equivalents (2018 - 2026) Analysis & Trends
At the end of FY2025, IRulya Therapeutics' Cash & Equivalents was $5.81 million, down 6.5% from FY2024.
- Cash & Equivalents has declined in each of the last four years, with a five-year compound annual growth rate of -38.7% (FY2020 to FY2025).
- Going back by year, Cash & Equivalents was $6.21 million in FY2024 (-70.1%), $20.75 million in FY2023 (-53.4%), $44.58 million in FY2022 (-36.1%) and $69.72 million in FY2021 (+4.3%).
- The Q2 2026 figure represents the highest quarterly Cash & Equivalents in data going back to Q1 2018.
- Year-over-year, Cash & Equivalents increased in four of the last eight quarters, with growth averaging 93.6%.
- The fastest year-over-year change in Cash & Equivalents over five years came in Q2 2026 (growth of 589.3%), and the weakest in Q3 2024 (a decline of 87.6%).
- Business Quant data shows IRLA's Cash & Equivalents at $18.16 million (Q1 2026), $5.81 million (Q4 2025) and $6.45 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,261.99 Bn | 1,235.61 Bn | 20.46 Bn | 4.89 Bn |
| 2 | Johnson & Johnson | 678.93 Bn | 598.79 Bn | 17.30 Bn | 16.91 Bn |
| 3 | AbbVie | 518.29 Bn | 486.30 Bn | 13.12 Bn | 10.77 Bn |
| 4 | Merck | 365.98 Bn | 328.92 Bn | 13.19 Bn | 9.55 Bn |
| 5 | Novartis Ag | 316.85 Bn | 290.09 Bn | - | 400.00 Mn |
| 6 | Astrazeneca | 293.40 Bn | 267.29 Bn | 13.26 Bn | 7.94 Bn |
| 7 | Amgen | 251.78 Bn | 203.43 Bn | 7.58 Bn | 13.19 Bn |
| 8 | Gilead Sciences | 210.61 Bn | 185.71 Bn | 6.73 Bn | 6.44 Bn |
| 9 | Pfizer | 166.87 Bn | 114.23 Bn | 12.56 Bn | 1.82 Bn |
| 10 | IRulya Therapeutics | 207.35 Mn | 91.35 Mn | - | 115.98 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 115.98 Mn |
| Mar 31, 2026 | 18.16 Mn |
| Dec 31, 2025 | 5.81 Mn |
| Sep 30, 2025 | 6.45 Mn |
| Jun 30, 2025 | 16.83 Mn |
| Mar 31, 2025 | 7.77 Mn |
| Dec 31, 2024 | 6.21 Mn |
| Sep 30, 2024 | 2.68 Mn |
| Jun 30, 2024 | 7.89 Mn |
| Mar 31, 2024 | 21.81 Mn |
| Dec 31, 2023 | 20.75 Mn |
| Sep 30, 2023 | 21.63 Mn |
| Jun 30, 2023 | 22.65 Mn |
| Mar 31, 2023 | 46.71 Mn |
| Dec 31, 2022 | 44.58 Mn |
| Sep 30, 2022 | 31.81 Mn |
| Jun 30, 2022 | 46.93 Mn |
| Mar 31, 2022 | 67.56 Mn |
| Dec 31, 2021 | 69.72 Mn |
| Sep 30, 2021 | 62.21 Mn |
API Access
IRulya Therapeutics Cash & Equivalents API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=IRLA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-equivalents", "ticker": "IRLA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=IRLA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();